Close Menu

NEW YORK (GenomeWeb) – Bionano Genomics has filed for an initial public offering in which it plans to raise up to $34.5 million.

According to a preliminary prospectus filed with the US Securities and Exchange Commission yesterday, the San Diego-based company plans to offer a yet to be determined number of shares of its common stock for a maximum aggregate offering price of $34.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.